Monoclonal Antibody Therapies in Multiple Myeloma: A Challenge to Develop Novel Targets

Figure 2

Humanized anti-CD26 monoclonal antibody (huCD26mAb): mechanisms of action huCD26mAb inhibits CD26 + MM cell growth chiefly via ADCC.